Remus Pharmaceuticals Limited IPO (Remus Pharmaceuticals IPO)

Remus Pharmaceuticals Limited IPO
Upcoming Remus Pharmaceuticals IPO | New Remus Pharmaceuticals IPO

Remus Pharmaceuticals Limited is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). Remus Pharmaceuticals also provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.

Remus Pharmaceuticals has its presence through registered and/or under registration products in countries namely Bhutan, Bolivia, Chile, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Kuwait, Madagascar, Malaysia, Hong kong, Myanmar, Panama, Trinidad and Tobago, Uzbekistan, Venezuela, Vietnam.

The company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

As on 31 January 2023, Companies product portfolio consists of 429 products. The company operate under different brand names across the

As on January 31, 2023, we have business to business supply agreements with 58 domestic distributors and 139 international distributors for distribution and/or contract manufacturing supply.

Remus Pharmaceuticals IPO

Remus Pharmaceuticals IPO – Details

IPO Opening Date17 May 2023
IPO Closing Date19 May 2023
Issue TypeBook Built Issue IPO
Issue Size3,88,000 Shares Worth ₹47.69 Crore
Fresh Issue: 33,20,000 Shares Worth ₹47.69 Crore
Face Value₹10 per equity share
IPO Price₹1150 – ₹1229
Market Lot100 Shares
Min Order100 Shares (1 Lot)
Listing AtNSE SME
RegisterLink Intime India Private Limited
QIB Shares Offered50%
Retail Shares Offered35%
NII (HNI) Shares Offered15%

Remus Pharmaceuticals IPO – Date Schedule

IPO Open Date17 May 2023
IPO Close Date19 May 2023
Basis of Allotment24 May 2023
Initiation of Refund25 May 2023
Credit of Shares to Demat Account26 May 2023
IPO Listing Date29 May 2023

Remus Pharmaceuticals IPO– Lots Size & Price

ApplicationLotsSharesAmount ( Cut-Off)
Retail (Minimum)11001,22,900
Retail (Maximum)11001,22,900
HNI (Minimum)22002,45,800

Competitive Strengths

  • Experienced Promoters and Management Team.
  • Wide range of Products.
  • Strategic Location of Contract Manufacturing Facilities.
  • Diversified business operations and revenue base.
  • Scalable Business Model.

Company Promoters

  • Mr. Arpit Deepakkumar Shah
  • Ms. Roma Vinodbhai Shah
  • Mr. Swapnil Jatinbhai Shah
  • Mrs. Anar Swapnil Shah

Object Of The Issue

  • To Meet Working Capital Requirements.
  • Funding investments for acquisitions and general corporate purposes.
  • To meet Public Issue Expenses.
Remus Pharmaceuticals IPO
Issue Object

Company Financial

ParticularsTotal RevenueTotal ExpenseProfit After Tax
31 March 202012.7611.670.81
31 March 202119.2217.861.02
31 March 202225.4320.883.38
31 December 202233.6124.916.43
Amount in ₹ Crore

Remus Pharmaceuticals IPO Promoter Holding

Pre Issue Share Holding92.16%
Post Issue Share Holding67.88%

Remus Pharmaceuticals IPO Prospectus

Company Contact Information

Remus Pharmaceuticals Limited

1101 to 1103, South Tower, One 42,
B/H Ashok Vatika, Nr. Jayantilal Park BRTS,
Ambli bopal Road, Ahmedabad –
380054, Gujarat, India

Phone: +079- 2999 9857

Remus Pharmaceuticals IPO Registrar

Link Intime India Private Limited

Phone: +91 810 811 4949

Remus Pharmaceuticals IPO Lead Manager(s)

1. Beeline Capital Advisors Private Limited

Remus Pharmaceuticals IPO FAQs

Remus Pharmaceuticals IPO FAQs
What is Remus Pharmaceuticals IPO?

Remus Pharmaceuticals IPO is a SME IPO. The issue is priced at ₹1150 – ₹1229 per equity share. The IPO is to be listed on NSE SME.
When Remus Pharmaceuticals IPO will open?

The IPO is to open on  17 May 2023 for QIB, NII and Retail Investors.
What is Remus Pharmaceuticals IPO Investors Portion?

The investors portion for QIB-50%NII-15%, and Retail-35%.
How to Remus Pharmaceuticals IPO?

You can apply Remus Pharmaceuticals IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
How to Apply the Remus Pharmaceuticals IPO through 5 Paisa?

Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Remus Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa.
How to Apply the Remus Pharmaceuticals IPO through Edelweiss?

Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Remus Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Edelweiss.
What is Remus Pharmaceuticals IPO Size?

Remus Pharmaceuticals IPO size is ₹47.69 crores.
What is Remus Pharmaceuticals IPO Price Band?

Remus Pharmaceuticals IPO Price Band is ₹1150-₹1229.
What is Remus Pharmaceuticals IPO Minimum and Maximum Lot Size?

The minimum bid is 100 Shares with ₹1,22,900 amount while the maximum bid is 100 shares with ₹1,22,900.
What is the Remus Pharmaceuticals IPO Allotment Date?

Remus Pharmaceuticals IPO allotment date is  24 May 2023.
What is the Remus Pharmaceuticals IPO Listing Date?

Remus Pharmaceuticals IPO listing date is  29 May 2023. The IPO is to list on NSE SME.
Share Market IPO App
Previous articleKrishca Strapping Solutions Limited IPO (Krishca Strapping Solutions IPO)
Next articleCrayons Advertising Limited IPO (Crayons Advertising IPO)